Anti-human transferrin receptor antibody capable of penetrating blood-brain barrier

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO RE50240
SERIAL NO

17161718

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided is an anti-human transferrin receptor antibody or an analog thereof, wherein in the heavy chain variable region of the antibody, (a) CDR1 comprises the amino acid sequence set forth as SEQ ID NO: 62 or SEQ ID NO: 63, (b) CDR2 comprises the amino acid sequence set forth as SEQ ID NO: 13 or SEQ ID NO: 14, and (c) CDR3 comprises the amino acid sequence set forth as SEQ ID NO: 15 or SEQ ID NO: 16, and an analogue thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
JCR PHARMACEUTICALS CO LTDASHIYA-SHI HYOGO 659-0021

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Sonoda, Hiroyuki Kobe, JP 32 381
Takahashi, Kenichi Kobe, JP 380 4379

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jun 24, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 24, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 24, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00